Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
enVVeno Medical ( (NVNO) ) has provided an announcement.
On November 17, 2025, enVVeno Medical Corporation’s Board of Directors approved an amendment to the company’s bylaws, specifically modifying the quorum requirement for stockholder meetings. The new amendment stipulates that a quorum is constituted by the presence, in person or by proxy, of holders of thirty-three and one-third percent of the voting power of outstanding shares, effective immediately upon approval.
Spark’s Take on NVNO Stock
According to Spark, TipRanks’ AI Analyst, NVNO is a Neutral.
enVVeno Medical’s overall stock score is influenced by its robust technical performance, which is somewhat overshadowed by challenging financial metrics. The company faces significant profitability issues, as reflected by its negative income and cash flow figures, despite having a stable balance sheet. While technical indicators show strong upward momentum, valuation concerns due to a negative P/E ratio and lack of dividends weigh on the score.
To see Spark’s full report on NVNO stock, click here.
More about enVVeno Medical
Average Trading Volume: 937,587
Technical Sentiment Signal: Sell
Current Market Cap: $6.4M
For detailed information about NVNO stock, go to TipRanks’ Stock Analysis page.